Medpace Holdings (MEDP) Operating Expenses (2015 - 2026)

Medpace Holdings (MEDP) has 12 years of Operating Expenses data on file, last reported at $560.5 million in Q2 2026.

• Quarterly Operating Expenses rose 17.51% year-over-year to $560.5 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $2.2 billion (up 25.34% YoY) and the FY2025 annual result came in at $2.0 billion, up 20.04% from the prior year.
• Operating Expenses retreated to $560.5 million in Q2 2026, from $565.1 million in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of $565.1 million in Q1 2026 to a low of $266.7 million in Q1 2022.
• A 5-year average of $417.4 million and a median of $411.1 million in 2023 frame the typical range for Operating Expenses.
• Annual changes were most pronounced in 2024 — Operating Expenses gained 0.03% — and 2025, when it jumped 35.01%.
• Tracing MEDP's Operating Expenses over 5 years: stood at $317.7 million in 2022, then grew by 29.41% to $411.1 million in 2023, then climbed by 0.03% to $411.2 million in 2024, then surged by 35.01% to $555.2 million in 2025, then gained by 0.96% to $560.5 million in 2026.
• The last three Operating Expenses figures came in at $560.5 million (Q2 2026), $565.1 million (Q1 2026), and $555.2 million (Q4 2025), per Business Quant data.